5 questions RWE & HEOR teams should ask data vendors in an RFP
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal...
Primary biliary cholangitis: Disease burden, treatments and RWD gaps
What real-world data reveals about the unique challenges of studying rare disease Primary biliary...
Insights in healthcare marketing start with truth, not inference
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...
Measuring psoriasis severity, outcomes and comorbidities using real-world data
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic...
How GLP-1 direct-to-consumer programs are distorting utilization trends
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
AI trends shaping healthcare in 2026: agentic, physical & sovereign AI
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in...
Understanding modern ulcerative colitis through real-world data
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
Understanding re-identification risk in PPRL
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....